Two-stage response to endotoxin infusion into normal human subjects:  Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response.
Taylor
F B
FB
Oklahoma Medical Research Foundation, Okalohoma City, USA.
Haddad
P A
PA
Hack
E
E
Chang
A C
AC
Peer
G T
GT
Morrissey
J H
JH
Li
A
A
Allen
R C
RC
Wada
H
H
Kinasewitz
G T
GT
D000328:Adult; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000276:immunology; D004731:Endotoxins / Q000009:adverse effects* / Q000276:immunology*; D004926:Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000097:blood* / Q000276:immunology*; D006487:Hemostasis / Q000276:immunology*; D006801:Humans; D007249:Inflammation; D007262:Infusions, Intravenous; D007958:Leukocyte Count; D008070:Lipopolysaccharides / Q000009:adverse effects* / Q000276:immunology*; D008163:Luminescent Measurements; D008297:Male; D010586:Phagocytes / Q000276:immunology*; D011971:Receptors, Immunologic / Q000276:immunology
D015415:Biomarkers; D004731:Endotoxins; D008070:Lipopolysaccharides; D011971:Receptors, Immunologic; C091196:opsonin receptor; D002097:C-Reactive Protein